Niagen Bioscience (NASDAQ:NAGE) is a global bioscience company focused on advancing NAD+ research and healthy-aging science. With a commitment to excellence, innovation, and integrity, Niagen collaborates with leading universities and research institutions to develop solutions that promote better aging. The company offers two primary product brands: Tru Niagen®, a clinically proven daily supplement that increases NAD+ levels, and Niagen® Plus, a premium pharmaceutical-grade NAD+ therapy brand. Niagen Bioscience is recognized for its scientific rigor and transparency, supported by extensive research including over 35 human clinical trials and 400 peer-reviewed studies. The company operates from two locations in California and a premier research laboratory in Longmont, CO, fostering a collaborative environment that values character, horsepower, and experience among its employees.